AstraZeneca Eyes Gilead in Big Pharma’s Move Beyond Covid
A logo sits at AstraZeneca Plc’s facilities in Sodertalje, Sweden. (Photographer: Mikael Sjoberg/Bloomberg)

AstraZeneca Eyes Gilead in Big Pharma’s Move Beyond Covid

(Bloomberg) -- Two drugmakers behind the industry’s most prominent responses to the Covid-19 pandemic are looking into the possibility of a combined future as economies emerge from lockdowns.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.